Altria Reports Q3 and 9-Month Operating Performance 2022

Nov.02.2022
Altria Reports Q3 and 9-Month Operating Performance 2022
Altria reported Q3 and 9-month results, narrowing their full-year EPS guidance and highlighting investments in non-smoking categories.

Altria Group has released its operational results for the third quarter and 9 months of 2022, and has revised its guidance for adjusted diluted earnings per share (EPS) for the full year of 2022.


Billy Gifford, CEO of Altria, stated in a press release that this is an exciting moment for the company as it moves towards its goal of going beyond smoking. Despite challenges in the tobacco industry in the first nine months of this year, Altria remained strong and rewarded its shareholders while investing in achieving its vision.


Altria's net profit dropped by 3.5 percent in the third quarter. The company's management remains optimistic, stating that their strategic actions have strengthened their product portfolio within the three major smokeless product categories. Altria has established an impressive selection of heated tobacco products and enhanced their competitiveness in the e-cigarette market, while further solidifying their position in the industry.


We are narrowing the guidance range for the full year of 2022, and the adjusted diluted earnings per share are expected to be within the range of $4.81 to $4.89. This represents a growth of 4.5% to 6% from the base of $4.61 in 2021. We believe that this range allows us to be flexible in responding to market conditions.


Net income for the third quarter decreased by 3.5% to 6.6 billion US dollars, due to a decline in net income for both the Michel wine business and the combustible products sector, partially offset by higher net income from the electronic cigarette sector. Revenue, after deducting sales taxes, decreased by 2.2%, to 5.4 billion US dollars.


The report shows a 100% increase in diluted earnings per share, reaching $0.12, mainly due to reduced losses reported by ABI investments (primarily due to a decrease in the company's impairment of ABI investments), favorable Cronos-related special projects, increased operating company income (OCI), and a decrease in outstanding shares, partially offset by adverse changes in the estimated fair value of the company's investment in Juul (including corresponding tax valuation allowances adjustments). Adjusted diluted earnings per share increased by 4.9% to $1.28, mainly due to increased adjusted other comprehensive income and a decrease in outstanding shares.


The company's net income for the first three quarters of the year decreased by 3.9%, to $19 billion, primarily due to the sale of its stake in Michelle Wine Estates and a decline in net income from its tobacco products sector. Revenue, excluding consumption tax, decreased by 2.6% to $15.6 billion.


Statement:


This article is compiled from third-party information and intended solely for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research.


Due to the limitations of our translation skills, the translated article may not fully reflect the original text. Please refer to the original version for accurate information.


In regards to any domestic, Hong Kong, Macau, Taiwan, or international issues, 2FIRSTS is aligned with the position and statements of the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is an infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
Japan Tobacco expands Ploom EVO stick lineup, rolling out four new variants in Japan in two phases
Japan Tobacco expands Ploom EVO stick lineup, rolling out four new variants in Japan in two phases
Japan Tobacco (JT) is adding four new EVO variants for its Ploom heated tobacco range—Green Mint, Cacao Mint Crystal, Tropical Lime Crystal and Sakura Regular—set to launch in two waves on Jan. 22 and Feb. 3. The initial release will be via the CLUB JT online store and Ploom retail stores.
Jan.23 by 2FIRSTS.ai
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Proposes 57% Vape Tax in $800M Revenue Plan
Michigan Governor Gretchen Whitmer’s FY2027 executive budget proposes a new 57% wholesale tax on vaping products and oral nicotine items as part of a broader $800 million revenue package aimed at stabilizing Medicaid funding.
Regulations
Feb.23
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov Region Eyes Full Vape Sales Ban, Signals Tighter Tobacco Retail Rules
Russia’s Rostov region is preparing to pursue a region-wide ban on vape sales and is also signaling support for broader regional powers to tighten tobacco retail rules. A regional lawmaker said the initiative aligns with a State Duma bill that would allow regions to impose vape sales bans—an initiative he said has presidential backing.
Jan.28 by 2FIRSTS.ai
Australian Government launches new phase of “Give Up For Good” to help people quit smoking and vaping
Australian Government launches new phase of “Give Up For Good” to help people quit smoking and vaping
On January 19, 2026, the Australian Government launched a new phase of the “Give Up For Good” campaign, adding resources and support for Australians looking to quit smoking and vaping.
Jan.19 by 2FIRSTS.ai